Zhejiang Provincial Engineering Research Center for Organelle Diagnostics and Therapy
The Zhejiang Engineering Research Center for Organelle Precision Diagnosis and Therapy was formally approved by the Zhejiang Provincial Development and Reform Commission in October 2024. Led by Eastern Institute of Technology, Ningbo, and directed by Academician Dayong Jin, it is jointly built with Ningbo No. 2 Hospital and two listed companies, Yongxin Optics and Meikang Biotech.
The center focuses on organelle research and applied technologies. Aiming to integrate industry, academia and research in organelle precision medicine and to train high-level engineering talent, it works in three research directions: digitized organelle interactions, exosome-based in vitro diagnostics, and precision micro- and nanoscale drug delivery. It develops new technologies and methods for precise diagnosis and treatment, addresses key problems in precision medicine, and advances both research and industrialization of organelle precision diagnosis and therapy in China. Its goal is to become a life and health base for Zhejiang Province and an important strategic force in China's biomedical innovation chain.
The center has strong talent in biomedical engineering, bringing together a group of leading scientists. Its laboratories have 67 staff, 42 of whom hold doctorates, including one foreign member of the Chinese Academy of Engineering, one Fellow of the Australian Academy of Technological Sciences and Engineering, two Fellows of the Canadian Academy of Engineering, nine national-level talents, three Zhejiang provincial key talents, two Ningbo municipal talents and 12 doctoral students. Together they form a top-tier team led by academicians, anchored by young and mid-career researchers, and supported by postdoctoral fellows and graduate students.
The center has undertaken a series of national, provincial and municipal research projects, earning research results, domestic and international awards, patents and software copyrights, and has published a body of high-level papers and monographs. It has 2,980 square meters of research space and an advanced research platform of 88 instruments and systems worth more than RMB 28 million, providing excellent conditions for its research. The center is committed to making outstanding contributions to ushering in the era of organelle precision diagnosis and therapy.
